Focal points in glycoprotein research
Tsurumi, K.
Rinsho Byori. Japanese Journal of Clinical Pathology 31(8): 843-849
1983
ISSN/ISBN: 0047-1860 PMID: 6655917 Document Number: 219912
Document emailed within 1 workday
Related Documents
Mizuno, H.; Kuroda, T. 1981: Focal points in modern medicine. 5. The life of the aged in Japan--the aging society in view of population dynamics Nursing Technique 27(2): 257-269Zamami, M.; Igarashi, T. 1987: Analysis and evaluation of case reports by students and a discussion on focal points in the preparation of the reports--comments on the reports presented at the past 14 issues Kurinikaru Sutadi 8(3): 296-302
Fombershteĭn, K.B. 1979: Anatomic topographic parallels between the pain points and acupuncture points and the effectiveness of local actions in lumbar osteochondrosis Ortopediia Travmatologiia i Protezirovanie 12: 14-16
Zlobin, V.I. 2000: Molecular epidemiology as a new research area in the study of natural and focal infections Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 12-15
Pérez Franco, B.; Manzano Cano, J.; Sánchez Librán, M.A.; Magaña Loarte, E. 1995: A focal group technique as a tool for evaluating a failed research project Atencion Primaria 16(10): 648-649
Buist, D.; Tuzzio, L.; Greenlee, R.; Field, T.; Williams, A.; Weinmann, S.; Stout, N.; Kamineni, A.; Doubeni, C. 2012: PS1-33: Cancer Screening Guideline Development, Implementation and Dissemination: Connection Points for Researchers and Health Care Delivery Systems for Comparative Effectiveness Research Clinical Medicine and Research 10(3): 157-157
Meshkat, Z.; Roostaee, M.H.; Soleimanjahi, M.; Zandi, K. 2012: Evaluation of antibodies against glycoprotein D (gD) and glycoprotein G (gG) in HSV-1 infected individuals' serum samples European Review for Medical and Pharmacological Sciences 16(4): 499-502
Schröder, C.M.; Ehmann, G. 1979: Focal diseases from the dental viewpoint. A statistical contribution to the problem of dentogenic focal disease and sequelae Zwr 88(8): 368-372
Chen, R.; Wang, C.; Yan, Q.-Y. 2014: Observation on therapeutic effect of polycystic ovary syndrome of damp-phlegm constitution treated with embedding therapy on back-shu points and front-mu points combined with needle-pricking therapy on Sifeng (EX-UE 10) Zhongguo Zhen Jiu 34(4): 355-358
Rumpelt, H.J.; Thoenes, W. 1973: Intraglomerular (immune) deposits in focal and segmental sclerosing glomerulopathy (-nephritis) (focal sclerotic lesion, hyalinose segmentaire et focale) Clinical Nephrology 1(6): 367-371
Izumi, T.; Pound, M.L.; Su, Z.; Iverson, G.M.; Ortel, T.L. 2002: Anti-beta(2)-glycoprotein i antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein i to phospholipids Thrombosis and Haemostasis 88(4): 620-626
Kitagawa, H.; Yamamoto, N.; Yamamoto, K.; Tanoue, K.; Kosaki, G.; Yamazaki, H. 1989: Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells Cancer Research 49(3): 537-541
Cotrufo, R. 1975: Neuronal control of the glycoprotein metabolism of skeletal muscles. Reinnervation of the gastrocnemius muscle of the rabbit: reversion of the changes induced by denervation in the content of glycoprotein N-acetyl-neuraminic acid and of total proteins of the homogenate Acta Neurologica 30(2): 181-187
Baas, F.; Jongsma, A.P.; Broxterman, H.J.; Arceci, R.J.; Housman, D.; Scheffer, G.L.; Riethorst, A.; van Groenigen, M.; Nieuwint, A.W.; Joenje, H. 1990: Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line Cancer Research 50(17): 5392-5398
Gressner, P.; Dahlmann, W.; Prill, A.; Rieling, K. 1973: Central nervous neurologic focal lesions in hypoglycemia. Changing neurologic focal symptoms due to glycopenia in islet-cell adenoma Medizinische Klinik 68(12): 371-376
Joo, K.M.; Song, S.Y.; Park, K.; Kim, M.H.; Jin, J.; Kang, B.G.; Jang, M.J.; Lee, G.S.; Kim, M.S.; Nam, D.-H. 2008: Response of brain specific microenvironment to P-glycoprotein inhibitor: an important factor determining therapeutic effect of P-glycoprotein inhibitor on brain metastatic tumors International Journal of Oncology 33(4): 705-712
Tarzia, R.; Meninno, V.; Lombardi, S.; Costanzo, A.; Canzano, G. 1984: Normal values of IgA, IgM, IgG, C3c, C4, alpha 1-acid glycoprotein in blood from the umbilical cord of healthy newborn infants using laser-nephelometry. III: C3c, C4, alpha 1-acid glycoprotein Bollettino della Societa Italiana di Biologia Sperimentale 60(2): 449-454
Kazama, Y.; Koide, T. 1992: Modulation of protein C inhibitor activity by histidine-rich glycoprotein and platelet factor 4: role of zinc and calcium ions in the heparin-neutralizing ability of histidine-rich glycoprotein Thrombosis and Haemostasis 67(1): 50-55
Dahms, A.S. 2002: Trends toward applied research, development, translational research, and application-oriented pure research: Challenges facing the basic research-focused molecular life science department and student training Biochemistry and Molecular Biology Education 30(3): 200-201
Peters, D.H.; Adam, T.; Alonge, O.; Agyepong, I.Akua.; Tran, N. 2014: Republished research: Implementation research: what it is and how to do it: implementation research is a growing but not well understood field of health research that can contribute to more effective public health and clinical policies and programmes. This article provides a broad definition of implementation research and outlines key principles for how to do it British journal of sports medicine 48(8): 731-736